Portage Biotech Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Alex Pickett
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 2.8yrs |
CEO
Alex Pickett
no data
Tenure
Mr. Alexander Pickett, also known as Alex, is CEO & Director of Portage Biotech Inc. from December 15, 2024. Mr. Pickett serves as Director of Morphoceuticals, Inc. He serves as the Principal at Mediqventu...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Scientific Officer | 5.9yrs | US$185.89k | 0.63% $ 36.2k | |
| Chief Business Officer | 2.8yrs | US$155.42k | no data | |
| CEO & Director | no data | no data | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Controller | less than a year | no data | no data |
0.3yrs
Average Tenure
Experienced Management: PRTG's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | no data | no data | no data | |
| Director | less than a year | no data | no data | |
| Independent Lead Director | 11.5yrs | US$49.50k | 9.01% $ 519.2k | |
| Independent Director | 8.7yrs | US$45.75k | 0.25% $ 14.2k | |
| Independent Director | 2.8yrs | US$35.24k | 13.08% $ 753.4k | |
| Director | less than a year | no data | no data | |
| Chairman of Board | 8.3yrs | US$717.89k | 1.35% $ 77.8k |
2.8yrs
Average Tenure
63yo
Average Age
Experienced Board: PRTG's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 23:43 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Portage Biotech Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Justin Walsh | B. Riley Securities, Inc. |
| Li Wang Watsek | Cantor Fitzgerald & Co. |
| Kevin DeGeeter | Oppenheimer & Co. Inc. |